Stream 6 Session #12: Free communications- GLP1RA-related therapies, diabetes and MAFLD
Tracks
Meeting Room 103
| Thursday, August 20, 2026 |
| 4:00 PM - 6:00 PM |
| Meeting Room 103 (Level 1) |
Speaker
Dr Ruth Frampton
PhD Student
Garvan Institute of Medical Research
Chairperson
Biography
Assoc Prof Tongzhi Wu
Associate Professor
Adelaide University
Chairperson
Biography
Prof Stephen Nicholls
Director, Victorian Heart Institute
Monash University
The effect of tirzepatide vs. dulaglutide on major adverse cardiovascular events (MACE-4 and MACE-5) in patients with type 2 diabetes and established atherosclerotic cardiovascular disease
4:00 PM - 4:15 PMBiography
Prof Stephen Nicholls is a world-renowned cardiologist and leads the Victorian Heart Hospital (VHH). A multiple-award winner, Professor Nicholls has written more than 770 manuscripts, book chapters and conference proceedings, and has raised more than $100 million in research funding.
Mr. Tianyu Wu
PhD Candidate
Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Prof Richard MacIsaac
Professor and Director of Endocrinology and Diabetes
St Vincent's Health University of Melbourne
Acute dip in eGFR in patients treated with tirzepatide. A post-hoc analysis of long-term clinical trials of tirzepatide treatment
4:30 PM - 4:45 PMBiography
Richard J MacIsaac is Professor and Director of Endocrinology, Department of Endocrinology & Diabetes, St Vincent’s Hospital Melbourne, Professorial Fellow, The University of Melbourne and Senior Principal Research Associate, St Vincent’s Institute of Medical Research, Melbourne, Victoria
Dr Sarah Parry
Endocrinologist
Royal Prince Alfred Hospital
MRI-PDFF ≥ 70% reduction was associated with fibrosis improvement with tirzepatide: post-hoc analysis of the SYNERGY-NASH phase 2b trial
4:45 PM - 5:00 PMBiography
Dr Sarah Parry is a Staff Specialist Endocrinologist at Royal Prince Alfred Hospital and RPA Health One Green Square. She has completed a PhD from the University of Sydney, researching drivers of metabolic liver disease in diabetes.
Ms Liyana Ahmad Zamri
Researcher
Institute for Medical Research (IMR)
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Phenotype Modulates Body Composition Remodelling and Hepatic Steatosis Improvement One Year After Bariatric Surgery
5:00 PM - 5:15 PMBiography
Liyana Ahmad Zamri is a researcher at the Institute for Medical Research, Malaysia, with publications in obesity, cardiometabolic health, and weight change. Her work focuses on metabolic risk markers, body composition, and obesity interventions, contributing to improved understanding of cardiometabolic outcomes in diverse clinical and population-based settings.
Miss Lixuan Fang
PhD Student
The Second Affiliated Hospital of Nanchang University
Semaglutide versus caloric restriction in people with newly diagnosed Type 2 Diabetes mellitus and overweight or obesity: A randomized controlled trial
5:15 PM - 5:30 PMBiography
Lixuan Fang is a PhD candidate in Endocrinology at the Second Affiliated Hospital of Nanchang University, Nanchang, China. Her research focuses on metabolic diseases and diabetes management. She is supervised by Professor Jianping Liu and is engaged in clinical and translational research in diabetes care.
Dr Matilda Longfield
Postdoctoral Researcher/ Clinical Trial Coordinator
Royal North Shore Hospital / Kolling Institute
Tirzepatide for the treatment of concurrent Type 1 Diabetes and overweight or obesity (TZP-T1D): An interim analysis.
5:30 PM - 5:45 PMBiography
Dr. Longfield is an Early Career Postdoctoral Researcher working within the Kolling Institute of Medical Research and Department of Diabetes, Metabolism and Endocrinology at the Royal North Shore Hospital under the leadership if Prof. Sarah Glastras. Her work spans clinical trials and basic science research focusing on clinical translation.
Assoc Prof Samantha Hocking
Endocrinologist
Royal Prince Alfred Hospital
Changes in physical function by degree of improvement in inflammatory biomarkers: a post-hoc analysis of SURMOUNT-2
5:45 PM - 6:00 PMBiography
Associate Professor Samantha Hocking is an Endocrinologist at Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. She is the current president of the National Association of Clinical Obesity Services (NACOS)
